Sanjeeva R Onteddu1, Richard P Goddeau1, Artin Minaeian1, Nils Henninger2. 1. Department of Neurology, University of Massachusetts Medical School, Worcester, MA, United States. 2. Department of Neurology, University of Massachusetts Medical School, Worcester, MA, United States; Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, United States. Electronic address: nils.henninger@umassmed.edu.
Abstract
BACKGROUND AND AIMS: Ischemic stroke remains a leading cause of disability, particularly among the elderly, but this association has not been consistently noted among patients with minor stroke. We sought to determine the association of chronological age and leukoaraiosis, which is considered a marker of biological age, with the degree of neurological deficit recovery and 90-day disability after minor ischemic stroke. METHODS: We retrospectively analyzed 185 patients with a minor ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score ≤ 5). Leukoaraiosis severity was graded according to the van Swieten scale. NIHSS was assessed at baseline, discharge, and 90-days. Multivariable linear and ordinal logistic regression analyses were constructed to identify independent predictors of the degree of NIHSS-improvement (ΔNIHSS) and 90-day outcome as assessed by the modified Rankin Scale (mRS). RESULTS: Patients with severe leukoaraiosis had attenuated ΔNIHSS at 90 days as compared to patients with none-to-mild leukoaraiosis (p=0.028). After adjustment, leukoaraiosis severity (p<0.001) but not chronological age (p=0.771) was independently associated with the ΔNIHSS by day 90. Severe leukoaraiosis (p=0.003, OR 3.1, 95%-CI 1.5-6.4), older age (p=0.001, OR 1.0 95%-CI 1.0-1.1), and admission NIHSS (p<0.001, OR 1.5, 95%-CI 1.2-1.8) were independent predictors of the 90-day mRS. CONCLUSION: Leukoaraiosis is a more sensitive predictor for neurological deficit recovery after ischemic stroke than chronological age. Further study is required to establish the specific contribution of leukoaraiosis to functional outcome after minor ischemic stroke beyond its impact on recovery mechanisms.
BACKGROUND AND AIMS: Ischemic stroke remains a leading cause of disability, particularly among the elderly, but this association has not been consistently noted among patients with minor stroke. We sought to determine the association of chronological age and leukoaraiosis, which is considered a marker of biological age, with the degree of neurological deficit recovery and 90-day disability after minor ischemic stroke. METHODS: We retrospectively analyzed 185 patients with a minor ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score ≤ 5). Leukoaraiosis severity was graded according to the van Swieten scale. NIHSS was assessed at baseline, discharge, and 90-days. Multivariable linear and ordinal logistic regression analyses were constructed to identify independent predictors of the degree of NIHSS-improvement (ΔNIHSS) and 90-day outcome as assessed by the modified Rankin Scale (mRS). RESULTS:Patients with severe leukoaraiosis had attenuated ΔNIHSS at 90 days as compared to patients with none-to-mild leukoaraiosis (p=0.028). After adjustment, leukoaraiosis severity (p<0.001) but not chronological age (p=0.771) was independently associated with the ΔNIHSS by day 90. Severe leukoaraiosis (p=0.003, OR 3.1, 95%-CI 1.5-6.4), older age (p=0.001, OR 1.0 95%-CI 1.0-1.1), and admission NIHSS (p<0.001, OR 1.5, 95%-CI 1.2-1.8) were independent predictors of the 90-day mRS. CONCLUSION:Leukoaraiosis is a more sensitive predictor for neurological deficit recovery after ischemic stroke than chronological age. Further study is required to establish the specific contribution of leukoaraiosis to functional outcome after minor ischemic stroke beyond its impact on recovery mechanisms.
Authors: Y Mayasi; R P Goddeau; M Moonis; B Silver; A H Jun-O'Connell; A S Puri; N Henninger Journal: AJNR Am J Neuroradiol Date: 2017-11-23 Impact factor: 3.825
Authors: Simone M Uniken Venema; Sandro Marini; Umme K Lena; Andrea Morotti; Michael Jessel; Charles J Moomaw; Christina Kourkoulis; Fernando D Testai; Steven J Kittner; H Bart Brouwers; Michael L James; Daniel Woo; Christopher D Anderson; Jonathan Rosand Journal: Stroke Date: 2019-08-26 Impact factor: 7.914
Authors: Muhammad Nagy; Muhammad U Azeem; Youssef Soliman; Sahil A Nawab; Adalia H Jun-O'Connell; Richard P Goddeau; Majaz Moonis; Brian Silver; Nils Henninger Journal: J Stroke Cerebrovasc Dis Date: 2019-01-07 Impact factor: 2.136
Authors: Mark R Etherton; Ona Wu; Anne-Katrin Giese; Arne Lauer; Gregoire Boulouis; Brittany Mills; Lisa Cloonan; Kathleen L Donahue; William Copen; Pamela Schaefer; Natalia S Rost Journal: Transl Stroke Res Date: 2019-01-28 Impact factor: 6.829
Authors: Mark R Etherton; Ona Wu; Pedro Cougo; Anne-Katrin Giese; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Gregoire Boulouis; Hasan H Karadeli; Arne Lauer; Jonathan Rosand; Karen L Furie; Natalia S Rost Journal: Neurology Date: 2017-04-05 Impact factor: 9.910